To test the idea that SOD2-mediated proteasomal protein degradation reflects a compensatory mechanism for cancer cells, we generated WNT/STOP-resistant T-ALL single-cell clones. This evidence concerns the gene MAP6 and acute lymphoblastic leukemia.